Authors: Basora, Josep, Buil Cosiales, Pilar, Bulló, Mònica, Corella Piquer, Dolores, Estruch Riba, Ramon, Fiol Sala, Miguel, Fitó Colomer, Montserrat, Guasch-Ferré, Marta, Gómez Gracia, Enrique, Hu, Frank B., Lamuela Raventós, Rosa Ma., Lapetra, José, Martínez, José Antonio, Martínez-González, Miguel Ángel, 1957-, Muñoz, M. A., Pintó Sala, Xavier, Recondo, J., Ros Rahola, Emilio, Ruiz-Gutiérrez, Valentina, Salas Salvadó, Jordi, Serra Majem, Lluís, Sorlí, José V.
Published: October 30, 2014
In a prospective cohort analysis of 7,216 men and women aged 55-80 at high cardiovascular risk from the PREDIMED trial (median follow-up 4.8 years, 277 cardiovascular events, 323 deaths), participants in the highest energy-adjusted tertile of extra-virgin olive oil consumption had a 39% cardiovascular disease risk reduction (HR: 0.61; 95% CI: 0.44 to 0.85) compared to the lowest tertile. For each 10 g/d increase in extra-virgin olive oil intake, cardiovascular disease risk decreased by 10% and mortality risk decreased by 7%. Higher total olive oil consumption was associated with a 48% reduced risk of cardiovascular mortality (HR: 0.52; 95% CI: 0.29 to 0.93). Associations were significant in the Mediterranean diet intervention groups.
